Yan Xia

This inventor holds 36 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 21 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Mayo Foundation for Medical Education and Research. Active years: 1990-2015.

USPTO Granted Patents = 36 (Patent Applications = 3)

% Patents Active = 94.4

CIPO Patents = 3

EPO Patents = 21 (Patent Applications = 11)

Average Co-Inventor Count = 4.5

ph-index = 10

Forward Citations = 364(Granted Patents)

Location History:

Baltimore, MD (US) (1990 - 1999)
Edison, PA (US) (2010 - 2012)
Edison, NJ (US) (1999 - 2015)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

2 out of 1,802

Mayo Foundation for Medical Education and Research

patents

4. 2 out of 52

Pharmacopeia Drug Discovery, Inc.

patents

5. 2 out of 1,955

University of Pittsburgh

Intervet International B.v.

Mochida Pharmaceutical Co., Ltd.

patents

10. 1 out of 28

Schering-Plough Corporation

patents

where one patent can have more than one assignee

Years Active: 1990-2015

Loading Chart...

Areas of Expertise:

BACE-1 Inhibitors

Thrombin Receptor Antagonists

GPCR Modulators

Factor IXA Inhibitors

Adenosine Receptor Antagonists

Morpholinone Compounds

Pyrimidine Derivatives

Cyclic Amine Compounds

Bicyclic Derivatives

Heterocyclic Compounds

Cannabinoid Receptor Modulators

Huperzine A

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9062007 - Cyclic amide BACE-1 inhibitors having a benzamide substituent (2015-06-23),

2. 8987242 - Morpholinone compounds as factor IXA inhibitors (2015-03-24),

3. 8987195 - HCV NS3 protease inhibitors (2015-03-24),

4. 8907095 - Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119 (2014-12-09),

5. 8722882 - Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes (2014-05-13),

6. 8642582 - Morpholinone compounds as factor IXa inhibitors (2014-02-04),

7. 8623867 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2014-01-07),

8. 8609676 - 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors (2013-12-17),

9. RE44205 - Adenosine Areceptor antagonists (2013-05-06),

10. 8278334 - Cyclic amine BACE-1 inhibitors having a benzamide substituent (2012-10-02),

11. 8153664 - Bicyclic and tricyclic derivatives as thrombin receptor antagonists (2012-04-10),

12. 8148363 - Heterocyclic compounds as factor IXA inhibitors (2012-04-03),

13. 8022088 - Substituted bicyclic and tricyclic thrombin receptor antagonists (2011-09-20),

14. 8003803 - Fused ring thrombin receptor antagonists (2011-08-23),

15. 7897601 - Cannabinoid receptor modulators (2011-03-01),

Title: Inventor Yan Xia - Pioneering Innovations in Edison, NJ

Introduction: Yan Xia is a visionary inventor based in Edison, NJ, known for her groundbreaking contributions to various technological fields.

Latest Patents: Yan Xia holds several patents in the areas of renewable energy, sustainable materials, and artificial intelligence, showcasing her diverse expertise and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Yan Xia has worked with leading research institutions and universities to develop cutting-edge solutions for complex challenges in the industry.

Collaborations: Throughout her career, Yan Xia has collaborated with top companies, innovative startups, and renowned inventors to bring her ideas to life and make a lasting impact on the world of technology.

Conclusion: Yan Xia's passion for innovation and her relentless pursuit of excellence continue to drive her to push the boundaries of what is possible, making her a true trailblazer in the field of inventions.